March 3, 2020 / 9:09 PM / a month ago

BRIEF-Morphosys, Incyte Announce Antitrust Clearance Of Global Collaboration And License Agreement For Tafasitamab

March 3 (Reuters) - Morphosys Ag:

* DGAP-NEWS: MORPHOSYS AND INCYTE ANNOUNCE ANTITRUST CLEARANCE OF GLOBAL COLLABORATION AND LICENSE AGREEMENT FOR TAFASITAMAB

* AGREEMENT BECOMING EFFECTIVE TRIGGERS $750 MILLION UPFRONT PAYMENT BY INCYTE TO MORPHOSYS

* MORPHOSYS - AGREEMENT BECOMING EFFECTIVE TRIGGERS INCYTE’S EQUITY INVESTMENT INTO CO OF $150 MILLION IN NEW ADS WITHIN DEFINED TIMELINES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below